This Week Last Year in Medtech: Jan. 29 – Feb. 4

Nevro Takes Medtronic to Task Over Diabetic Neuropathy Data

Nevro criticizes Medtronic's use of older, smaller European studies to support its recent FDA approval of spinal cord stimulation therapy for treating painful diabetic neuropathy.

Glooko Keeps Diabetes Management Space Hot with M&A

The Palo Alto, CA-based company is adding machine learning to its arsenal with the acquisition of xbird.

Omicron Strikes Stryker, But Mako Saves the Day

The Kalamazoo, MI-based company slightly missed consensus for EPS.

Fractyl Brings the Heat to Diabetes with Revita Data

The Lexington, MA-based company publishes two-year data that comes on the heels of some major developments in the diabetes market.

Medtronic Accused of Stealing Business from Globus Medical

Medtronic denies any wrongdoing, but Globus Medical has filed a lawsuit accusing Medtronic and four sales reps (formerly Globus reps) of stealing business.

FDA Clears Credit-Card-Sized Personal EKG Device

AliveCors launched the KardiaMobile Card, a personal ECG (electrocardiogram) device the size of a credit card. What's in your wallet?

BD’s Diabetes Spinoff Gets Name and Launch Date

The Franklin Lakes, NJ-based company said the new spinoff will be named Embecta.

InnovHeart Shows it Has Heart with New Financing

The Milan, Italy-based company raised $55 million in a series C round.

Vantari VR Debuts 'World’s First' Virtual Right Heart Catheter Course

The Australian medical virtual reality company has partnered with an internationally renowned cardiologist to revolutionize clinician training.